An “inverse vaccine” that delivers deactivated allergens to the liver was able to reduce reactions in mice with allergic asthma for at least a year after treatment. Should the approach ...

Research conducted by the National Cancer Research Centre (CNIO), published today in ‘Nature’, reveals a mechanism in mice that is triggered just minutes after acute liver damage occurs.

The global humanized liver mice model market is on a strong growth trajectory, fueled by the increasing prevalence of liver diseases and significant technological advancements in genetic engineering.